SEER INC. news, videos and press releases
For more news please use our advanced search feature.
SEER INC. - More news...
SEER INC. - More news...
- Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
- Seer to Participate in Upcoming November Investor Conferences
- Seer Reports Third Quarter 2024 Financial Results
- Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
- Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
- Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024
- Seer to Report Third Quarter 2024 Financial Results on November 6, 2024
- Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Seer Appoints Nicolas Roelofs to its Board of Directors
- Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Seer Reports Second Quarter 2024 Financial Results
- Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
- Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
- Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
- Seer Reports First Quarter 2024 Financial Results
- Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
- Seer to Report First Quarter 2024 Financial Results on May 8, 2024
- Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
- Seer to Participate in the TD Cowen 44th Annual Health Care Conference
- Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
- Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
- Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
- Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
- Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
- Seer Reports Third Quarter 2023 Financial Results
- Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
- Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
- Seer to Participate in Upcoming September Investor Conferences
- Seer Reports Second Quarter 2023 Financial Results
- Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference
